EDWARD M JANG
Allopathic & Osteopathic Physicians|Internal Medicine LA PALMA, CA NPI 1790966992
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine CA Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$121.40
- Category: General Payments
- Program years: PY2018
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2018): $121.40 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2018) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $121.40 | 8 |
By paying entity
Latest program year (PY2018) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $33.01 | 2 |
| Janssen Pharmaceuticals, Inc | $24.23 | 2 |
| Astellas Pharma US Inc | $20.51 | 1 |
| SANOFI-AVENTIS U.S. LLC | $17.86 | 1 |
| Merck Sharp & Dohme Corporation | $14.76 | 1 |
| Lilly USA, LLC | $11.03 | 1 |
By program year
| Program year | Amount | Records |
|---|---|---|
| 2018 | $121.40 | 8 |
Records — PY2018 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 549117721 | Janssen Pharmaceuticals, Inc | $11.58 | 01/24/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 549117723 | Janssen Pharmaceuticals, Inc | $12.65 | 04/05/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 559291133 | Lilly USA, LLC | $11.03 | 03/01/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 578519601 | Boehringer Ingelheim Pharmaceuticals, Inc. | $18.32 | 04/11/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 578519839 | Boehringer Ingelheim Pharmaceuticals, Inc. | $14.69 | 02/20/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 582537045 | Astellas Pharma US Inc | $20.51 | 03/29/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 602018777 | SANOFI-AVENTIS U.S. LLC | $17.86 | 03/16/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 604300395 | Merck Sharp & Dohme Corporation | $14.76 | 03/28/2018 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.